Skip to content

    Teladoc Health (TDOC) stock price & financials

    View TDOC earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance16.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $640.51M
    $640.49M
    $629.37M
    $631.90M
    $626.44M
    -2.2%
    $642.27M
    +0.3%
    $613.85M
    -2.5%
    $606.93M
    -4.0%
    Stable
    Operating Profit
    -$44.40M
    -$48.22M
    -$120.61M
    -$54.38M
    -$51.96M
    -17.0%
    -$36.00M
    +25.3%
    -$61.77M
    +48.8%
    -$37.09M
    +31.8%
    Strengthening
    Net Profit
    -$33.28M
    -$48.41M
    -$93.01M
    -$32.66M
    -$49.51M
    -48.8%
    -$25.14M
    +48.1%
    -$63.84M
    +31.4%
    -$38.91M
    -19.1%
    Strengthening
    EPS
    $-0.19
    $-0.53
    $-0.19
    $-0.28
    -47.4%
    $-0.36
    +32.1%
    $-0.21
    -10.5%
    Strengthening
    Other Income
    Interest
    $5.66M
    $6.85M
    $5.76M
    $4.47M
    $4.53M
    -20.0%
    $4.95M
    -27.7%
    $5.37M
    -6.9%
    $5.11M
    +14.2%
    Weakening
    Depreciation
    Profit before Tax
    -$32.50M
    -$48.17M
    -$111.27M
    -$40.42M
    -$50.22M
    -54.5%
    -$33.62M
    +30.2%
    -$60.84M
    +45.3%
    -$37.91M
    +6.2%
    Strengthening
    MarginsOPM
    -6.9%
    -7.5%
    -19.2%
    -8.6%
    -8.3%
    -19.6%
    -5.6%
    +25.6%
    -10.1%
    +47.5%
    -6.1%
    +29.0%
    Strengthening
    Tax
    -2.4%
    -0.5%
    16.4%
    19.2%
    1.4%
    25.2%
    -4.9%
    -130.0%
    -2.6%
    -113.7%
    Weakening
    ReturnsROIC
    0.2%
    0.3%
    0.6%
    0.2%
    0.3%
    +48.8%
    0.2%
    -48.1%
    0.4%
    -31.4%
    0.2%
    +19.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$423.99M$514.35M$733.32M$893.48M$918.18M$1.12B$1.30B$781.08M$774.35M
    Short-Term Investments
    Total Current Assets$532.74M$588.00M$1.06B$1.23B$1.32B$1.49B$1.66B$1.12B$1.15B
    Net PP&E$10.15M$36.75M$75.20M$74.01M$71.47M$72.09M$56.58M$53.09M$47.41M
    Goodwill$737.20M$746.08M$14.58B$14.50B$1.07B$1.07B$283.19M$283.19M$283.19M
    Intangibles$247.39M$225.45M$2.02B$1.91B$1.84B$1.68B$1.43B$1.30B$1.18B
    Total Assets$1.53B$1.60B$17.76B$17.73B$4.35B$4.39B$3.52B$2.86B$2.76B
    LiabilitiesTotal Current Liabilities$62.44M$90.18M$332.65M$331.01M$399.77M$420.62M$941.53M$404.74M$1.38B
    Short-Term Debt$0$42.56M$0
    Long-Term Debt
    Long-Term Leases$0$24.99M$43.14M$41.77M$38.04M$42.84M$32.13M$34.20M$29.54M
    Total Liabilities$515.76M$588.80M$1.87B$1.69B$2.04B$2.07B$2.03B$1.47B$1.45B
    EquityCommon Stock & APIC$70.0K$73.0K$150.0K$160.0K$163.0K$167.0K$173.0K$178.0K$182.0K
    Retained Earnings-$408.66M-$507.52M-$992.66M-$1.42B-$15.01B-$15.23B-$16.23B-$16.43B-$16.53B
    Total Equity$1.01B$1.01B$15.88B$16.05B$2.31B$2.33B$1.49B$1.39B$1.31B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$4.86M$29.87M-$53.51M$193.99M$189.29M$350.02M$293.68M$294.36M$261.18M
    Cash from Investing-$257.50M$25.01M-$590.98M-$72.98M-$167.74M-$156.35M-$124.05M-$266.00M-$161.15M
    Cash from Financing$645.61M$35.09M$859.14M$40.95M$6.50M$10.85M$8.31M-$551.65M-$4.06M
    SummaryCapital Expenditure-$4.01M-$3.51M-$4.02M-$8.53M-$16.48M-$11.46M-$10.79M-$8.89M-$7.49M
    Free Cash Flow-$8.87M$26.36M-$57.53M$185.46M$172.81M$338.56M$282.89M$285.46M$253.70M
    FCF Margin-2.1%4.8%-5.3%9.1%7.2%13.0%11.0%11.3%10.2%

    Ratios